Skip to main content

Psychiatric disorders and SLC6A4 gene variants: possible effects on alcohol dependence and alzheimer’s disease

Molecular Biology Reports volume 47, pages 191–200 (2020)Cite this article

A Correction to this article was published on 22 January 2020

This article has been updated

Abstract

Serotoninergic system is one of the most important neurotransmission systems investigated in the field of psychiatry. Extensive evidence reveals how alterations of this system, and especially of the SLC6A4 gene, may be associated with psychiatric disorders. In this study we aimed to evaluate the pleiotropic nature of SLC6A4 alterations and their association with the overall risk of brain diseases rather than disorder-specific. SLC6A4 variants, namely 5HTTLPR, STin2, rs2066713, rs25531, rs4251417, rs6354 and rs7224199 were investigated in 4 independent cohorts of subjects with specific psychiatric disorders, including Alcohol dependence disorder (ALC), Alzheimer disease (ALZ), Schizophrenia (SCZ) and Bipolar disorder (BPD). Other variables (biochemical parameters and Psychiatric scales scores) were also tested for association. SLC6A4 polymorphisms are not associated with the risk of developing major psychiatric disorders (SCZ and BPD); however some signals were detected in ALC (HTTLPR pd = 9.25 × 10−03, pr = 7.24 × 10−03; rs2066713 pd = 6.35 × 10−08; rs25531 pd = 2.95 × 10−02; rs4251417 pd = 2.46 × 10−03), and ALZ (rs6354 pr = 1.22 × 10−02; rs7224199 pd = 1.00 × 10−08, pr = 2.65 × 10−02) cohorts. Some associations were also observed on exploratory analyses. Our findings did not reveal any major influence on SCZ and BPD development; On the other hand, some alteration of the SLC6A4 sequence were associated with an increased risk of ALC and ALZ disorders, suggesting common pathways. The results of this study should be carefully interpreted since it suffers of some inherent limitations (e.g. cohort size, slight ethnic heterogeneity). Further analyses may provide better detail on the molecular processes behind SLC6A4 alterations.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1
Chart 1
Chart 2

Change history

  • 22 January 2020

    The following authors have double affiliations: <Emphasis Type="Bold">Stefania Boccia, Marco Di Nicola</Emphasis> and they should read

  • 22 January 2020

    The following authors have double affiliations: Stefania Boccia, Marco Di Nicola and they should read

References

  1. Fuller RW (1996) Mechanisms and functions of serotonin neuronal systems: opportunities for neuropeptide interactions. Ann NY Acad Sci 780:176–184

    CAS  PubMed  Google Scholar 

  2. Hensler JG, Artigas F, Bortolozzi A, Daws LC, De Deurwaerdere P, Milan L, Navailles S, Koek W (2013) Catecholamine/serotonin interactions: systems thinking for brain function and disease. Adv Pharmacol 68:167–197

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Lesch KP, Merschdorf U (2000) Impulsivity, aggression, and serotonin: a molecular psychobiological perspective. Behav Sci Law 18(5):581–604

    CAS  PubMed  Google Scholar 

  4. Linnoila VM, Virkkunen M (1992) Aggression, suicidality, and serotonin. J Clin Psychiatry 53(Suppl):46–51

    PubMed  Google Scholar 

  5. Dell’Osso L, Carmassi C, Mucci F, Marazziti D (2016) Depression, serotonin and tryptophan. Curr Pharm Des 22(8):949–954

    PubMed  Google Scholar 

  6. Mahmood T, Silverstone T (2001) Serotonin and bipolar disorder. J Affect Disord 66(1):1–11

    CAS  PubMed  Google Scholar 

  7. Cross AJ (1990) Serotonin in Alzheimer-type dementia and other dementing illnesses. Ann NY Acad Sci 600:405–415 discussion 415-407

    CAS  PubMed  Google Scholar 

  8. Gorwood P, Lanfumey L, Hamon M (2004) Alcohol dependence and polymorphisms of serotonin-related genes. Med Sci (Paris) 20(12):1132–1138

    Google Scholar 

  9. Calabro M, Fabbri C, Crisafulli C, Albani D, Forloni G, Kasper S, Sidoti A, Velardi E, Zohar J, Juven-Wetzler A, Souery D, Montgomery S, Mendlewicz J, Serretti A (2018) The serotonin transporter and the activity regulated cytoskeleton-associated protein genes in antidepressant response and resistance: 5-HTTLPR and other variants. Hum Psychopharmacol 33(6):e2682

    PubMed  Google Scholar 

  10. Coplan JD, Gopinath S, Abdallah CG, Berry BR (2014) A neurobiological hypothesis of treatment-resistant depression - mechanisms for selective serotonin reuptake inhibitor non-efficacy. Front Behav Neurosci 8:189

    PubMed  PubMed Central  Google Scholar 

  11. Hofer P, Schosser A, Calati R, Serretti A, Massat I, Kocabas NA, Konstantinidis A, Mendlewicz J, Souery D, Zohar J, Juven-Wetzler A, Montgomery S, Kasper S (2016) The impact of serotonin receptor 1A and 2A gene polymorphisms and interactions on suicide attempt and suicide risk in depressed patients with insufficient response to treatment–a European multicentre study. Int Clin Psychopharmacol 31(1):1–7

    PubMed  Google Scholar 

  12. Rotondo A, Mazzanti C, Dell’Osso L, Rucci P, Sullivan P, Bouanani S, Gonnelli C, Goldman D, Cassano GB (2002) Catechol o-methyltransferase, serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar disorder patients with and without comorbid panic disorder. Am J Psychiatry 159(1):23–29

    PubMed  Google Scholar 

  13. Ho LW, Furlong RA, Rubinsztein JS, Walsh C, Paykel ES, Rubinsztein DC (2000) Genetic associations with clinical characteristics in bipolar affective disorder and recurrent unipolar depressive disorder. Am J Med Genet 96(1):36–42

    CAS  PubMed  Google Scholar 

  14. Bevilacqua L, Goldman D (2011) Genetics of emotion. Trends Cogn Sci 15(9):401–408

    PubMed  PubMed Central  Google Scholar 

  15. Thompson MD, Kenna GA (2016) Variation in the serotonin transporter gene and alcoholism: risk and response to pharmacotherapy. Alcohol Alcohol 51(2):164–171

    CAS  PubMed  Google Scholar 

  16. Nomura M, Kaneko M, Okuma Y, Nomura J, Kusumi I, Koyama T, Nomura Y (2015) Involvement of serotonin transporter gene polymorphisms (5-HTT) in impulsive behavior in the japanese population. PLoS ONE 10(3):e0119743

    PubMed  PubMed Central  Google Scholar 

  17. Albani D, Prato F, Tettamanti M, Lovati C, Galimberti D, Restelli I, Mariani C, Quadri PL, Scarpini E, Lucca U, Forloni G (2009) The serotonin transporter promoter polymorphic region is not a risk factor for Alzheimer’s disease related behavioral disturbances. J Alzheimers Dis 18(1):125–130

    CAS  PubMed  Google Scholar 

  18. Prasad HC, Steiner JA, Sutcliffe JS, Blakely RD (2009) Enhanced activity of human serotonin transporter variants associated with autism. Philos Trans R Soc Lond B Biol Sci 364(1514):163–173

    CAS  PubMed  Google Scholar 

  19. Rao S, Leung CS, Lam MH, Wing YK, Waye MM, Tsui SK (2017) Resequencing three candidate genes discovers seven potentially deleterious variants susceptibility to major depressive disorder and suicide attempts in Chinese. Gene 603:34–41

    CAS  PubMed  Google Scholar 

  20. Shi M, Hu J, Dong X, Gao Y, An G, Liu W, Chen L, Sun X (2008) Association of unipolar depression with gene polymorphisms in the serotonergic pathways in Han Chinese. Acta Neuropsychiatr 20(3):139–144

    PubMed  Google Scholar 

  21. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274(5292):1527–1531

    CAS  PubMed  Google Scholar 

  22. Shiroma PR, Drews MS, Geske JR, Mrazek DA (2014) SLC6A4 polymorphisms and age of onset in late-life depression on treatment outcomes with citalopram: a sequenced treatment alternatives to relieve depression (STAR*D) report. Am J Geriatr Psychiatry 22(11):1140–1148

    PubMed  Google Scholar 

  23. Kenna GA, Roder-Hanna N, Leggio L, Zywiak WH, Clifford J, Edwards S, Kenna JA, Shoaff J, Swift RM (2012) Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy. Pharmacogenom Personal Med 5:19–35

    CAS  Google Scholar 

  24. Thompson MD, Kenna GA (2016) Variation in the serotonin transporter gene and alcoholism: risk and response to pharmacotherapy. Alcohol Alcohol (Oxford, Oxfordshire) 51(2):164–171

    CAS  Google Scholar 

  25. Stacey D, Cohen-Woods S, Toben C, Arolt V, Dannlowski U, Baune BT (2013) Evidence of increased risk for major depressive disorder in individuals homozygous for the high-expressing 5-HTTLPR/rs25531 (L(A)) allele of the serotonin transporter promoter. Psychiatr Genet 23(5):222–223

    PubMed  Google Scholar 

  26. MacKenzie A, Quinn J (1999) A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. Proc Natl Acad Sci USA 96(26):15251–15255

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Drago A, Liappas I, Petio C, Albani D, Forloni G, Malitas P, Piperi C, Politis A, Tzavellas EO, Zisaki KK, Prato F, Batelli S, Polito L, De Ronchi D, Paparrigopoulos T, Kalofoutis A, Serretti A (2009) Epistasis between IL1A, IL1B, TNF, HTR2A, 5-HTTLPR and TPH2 variations does not impact alcohol dependence disorder features. Int J Environ Res Public Health 6(7):1980–1990

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Serretti A, Olgiati P, Politis A, Malitas P, Albani D, Dusi S, Polito L, De Mauro S, Zisaki A, Piperi C, Liappas I, Stamouli E, Mailis A, Atti AR, Morri M, Ujkaj M, Batelli S, Forloni G, Soldatos CR, Papadimitriou GN, De Ronchi D, Kalofoutis A (2009) Lack of association between interleukin-1 alpha rs1800587 polymorphism and Alzheimer’s disease in two independent European samples. J Alzheimers Dis 16(1):181–187

    CAS  PubMed  Google Scholar 

  29. De Ronchi D, Berardi D, Menchetti M, Ferrari G, Serretti A, Dalmonte E, Fratiglioni L (2005) Occurrence of cognitive impairment and dementia after the age of 60: a population-based study from Northern Italy. Dement Geriatr Cogn Disord 19(2–3):97–105

    PubMed  Google Scholar 

  30. Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198

    CAS  PubMed  Google Scholar 

  31. Alexopoulos GS, Abrams RC, Young RC, Shamoian CA (1988) Cornell scale for depression in dementia. Biol Psychiatry 23(3):271–284

    CAS  PubMed  Google Scholar 

  32. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44(12):2308–2314

    CAS  PubMed  Google Scholar 

  33. Morris JC (1993) The clinical dementia rating (cdr): current version and scoring rules. Neurology 43(11):2412–2414

    CAS  PubMed  Google Scholar 

  34. Roth M, Tym E, Mountjoy CQ, Huppert FA, Hendrie H, Verma S, Goddard R (1986) CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 149:698–709

    CAS  PubMed  Google Scholar 

  35. Corponi F, Bonassi S, Vieta E, Albani D, Frustaci A, Ducci G, Landi S, Boccia S, Serretti A, Fabbri C (2019) Genetic basis of psychopathological dimensions shared between schizophrenia and bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 89:23–29

    PubMed  Google Scholar 

  36. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21(2):263–265

    CAS  PubMed  Google Scholar 

  37. Porcelli S, Fabbri C, Serretti A (2012) Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy. Eur Neuropsychopharmacol 22(4):239–258

    CAS  PubMed  Google Scholar 

  38. Ho PS, Shih MC, Ma KH, Huang WS, Ho KK, Yen CH, Lu RB, Huang SY (2011) Availability of the serotonin transporter in patients with alcohol dependence. World J Biol Psychiatry 12(2):134–142

    CAS  PubMed  Google Scholar 

  39. Wendland JR, Martin BJ, Kruse MR, Lesch KP, Murphy DL (2006) Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. Mol Psychiatry 11(3):224–226

    CAS  PubMed  Google Scholar 

  40. Kobiella A, Reimold M, Ulshofer DE, Ikonomidou VN, Vollmert C, Vollstadt-Klein S, Rietschel M, Reischl G, Heinz A, Smolka MN (2011) How the serotonin transporter 5-HTTLPR polymorphism influences amygdala function: the roles of in vivo serotonin transporter expression and amygdala structure. Transl Psychiatry 1:e37

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Villalba K, Attonito J, Mendy A, Devieux JG, Gasana J, Dorak TM (2015) A meta-analysis of the associations between the SLC6A4 promoter polymorphism (5HTTLPR) and the risk for alcohol dependence. Psychiatr Genet 25(2):47–58

    CAS  PubMed  Google Scholar 

  42. Yang J, Li MD (2014) Association and interaction analyses of 5-HT3 receptor and serotonin transporter genes with alcohol, cocaine, and nicotine dependence using the SAGE data. Hum Genet 133(7):905–918

    CAS  PubMed  Google Scholar 

  43. Desmet FO, Hamroun D, Lalande M, Collod-Beroud G, Claustres M, Beroud C (2009) Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res 37(9):e67

    PubMed  PubMed Central  Google Scholar 

  44. Lam D, Ancelin ML, Ritchie K, Freak-Poli R, Saffery R, Ryan J (2018) Genotype-dependent associations between serotonin transporter gene (SLC6A4) DNA methylation and late-life depression. BMC Psychiatry 18(1):282

    PubMed  PubMed Central  Google Scholar 

  45. Janssen PK, Olivier B, Zwinderman AH, Waldinger MD (2014) Measurement errors in polymerase chain reaction are a confounding factor for a correct interpretation of 5-HTTLPR polymorphism effects on lifelong premature ejaculation: a critical analysis of a previously published meta-analysis of six studies. PLoS ONE 9(3):e88031

    PubMed  PubMed Central  Google Scholar 

  46. Yamazaki K, Yoshino Y, Mori T, Okita M, Yoshida T, Mori Y, Ozaki Y, Sao T, Iga J, Ueno S (2016) Association study and meta-analysis of polymorphisms, methylation profiles, and peripheral mrna expression of the serotonin transporter gene in patients with alzheimer’s disease. Dement Geriatr Cogn Disord 41(5–6):334–347

    CAS  PubMed  Google Scholar 

  47. Dolan M, Anderson IM, Deakin JF (2001) Relationship between 5-HT function and impulsivity and aggression in male offenders with personality disorders. Br J Psychiatry 178:352–359

    CAS  PubMed  Google Scholar 

  48. LeMarquand D, Pihl RO, Benkelfat C (1994) Serotonin and alcohol intake, abuse, and dependence: findings of animal studies. Biol Psychiatry 36(6):395–421

    CAS  PubMed  Google Scholar 

  49. Border R, Johnson EC, Evans LM, Smolen A, Berley N, Sullivan PF, Keller MC (2019) No support for historical candidate gene or candidate gene-by-interaction hypotheses for major depression across multiple large samples. Am J Psychiatry 176(5):376–387

    PubMed  PubMed Central  Google Scholar 

  50. Cai N, Kendler KS, Flint J (2018) Minimal phenotyping yields GWAS hits of low specificity for major depression. BioRxiv. https://doi.org/10.1101/440735

    Article  Google Scholar 

  51. Chen YC, Prescott CA, Walsh D, Patterson DG, Riley BP, Kendler KS, Kuo PH (2011) Different phenotypic and genotypic presentations in alcohol dependence: age at onset matters. J Stud Alcohol Drugs 72(5):752–762

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank all patients who gave their consent for the analysis of their data.

Funding

None.

Author information

Authors and Affiliations

  1. Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy

    Marco Calabrò & Concetta Crisafulli

  2. Department of Biomedical and NeuroMotor Sciences, University of Bologna, Viale Carlo Pepoli 5, 40123, Bologna, Italy

    Laura Mandelli, Stefano Porcelli & Alessandro Serretti

  3. Laboratory of Biology of Neurodegenerative Disorders, Neuroscience Department, Istituto di Ricerche Farmacologiche Mario Negri IRCSS, Milan, Italy

    Diego Albani

  4. Department of Psychiatry, University of Athens Medical School, Eginition Hospital, Athens, Greece

    Antonis Politis & George N. Papadimitriou

  5. Fondazione Policlinico Universitario “A. Gemelli” - IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy

    Marco Di Nicola, Luigi Janiri & Roberto Colombo

  6. Department of Neuroscience, Imaging and Clinical Sciences, University “G. d’Annunzio” of Chieti, Chieti, Italy

    Giovanni Martinotti

  7. Psychiatry Unit, Department of Medical Sciences, University of Foggia, Foggia, Italy

    Antonello Bellomo

  8. Bipolar Disorders Unit, Institute of Neuroscience, Hospital Clínic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain

    Eduard Vieta

  9. Unit of Clinical and Molecular Epidemiology, IRCCS San Raffaele Pisana, Rome, Italy, and Department of Human Sciences and Quality of Life Promotion, San Raffaele University, Rome, Italy

    Stefano Bonassi

  10. Barnet, Enfield and Haringey Mental Health NHS Trust, St.Ann’s Hospital, St.Ann’s Road, London, N15 3 TH, UK

    Alessandra Frustaci

  11. Mental Health Department, ASL Roma 1, Rome, Italy

    Giuseppe Ducci

  12. Dipartimento di Biologia, Università di Pisa, Pisa, Italy

    Stefano Landi

  13. Section of Hygiene, Institute of Public Health, Universita’ Cattolica del Sacro Cuore, Fondazione Policlinico “Agostino Gemelli” IRCCS, Rome, Italy

    Stefania Boccia

Authors
  1. Marco Calabrò
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura Mandelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Concetta Crisafulli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Stefano Porcelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Diego Albani
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Antonis Politis
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. George N. Papadimitriou
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Marco Di Nicola
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Luigi Janiri
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Roberto Colombo
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Giovanni Martinotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Antonello Bellomo
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Eduard Vieta
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Stefano Bonassi
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Alessandra Frustaci
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Giuseppe Ducci
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Stefano Landi
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Stefania Boccia
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Alessandro Serretti
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors were actively involved in the design of the study, the analytical method of the study, the selection and review of all scientific content. All authors had full editorial control during the writing of the manuscript and finally approved it.

Corresponding author

Correspondence to Alessandro Serretti.

Ethics declarations

Conflict of interest

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or conflict with that can be associated with the subject matter discussed in this manuscript.

Ethical approval

The authors declare that all procedures followed were approved by the national ethical committee. Further, all patients gave their written consent for the analysis of their data.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 834 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Calabrò, M., Mandelli, L., Crisafulli, C. et al. Psychiatric disorders and SLC6A4 gene variants: possible effects on alcohol dependence and alzheimer’s disease. Mol Biol Rep 47, 191–200 (2020). https://doi.org/10.1007/s11033-019-05119-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-019-05119-5

Keywords

  • SLC6A4
  • Alzheimer’s disease
  • Alcohol dependence disorder
  • Genetics
  • Schizophrenia
  • Bipolar disorder